20 results
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_/

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Management Algorithm ... - IDSA 2019 Guidelines ... _carlemd_/ #Pneumonia ... #Management #Algorithm ... Inpatient #HAP #HCAP #Treatment
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Management Algorithm ... - IDSA 2019 Guidelines ... /_carlemd_ #Pneumonia ... #Management #Algorithm ... Inpatient #HAP #HCAP #Treatment
IDSA Recommended antimicrobial regimens for treatment of patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens
IDSA Recommended ... antimicrobial regimens for treatment ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... #Regimens #IDSA
CAP, HCAP, HAP and VAP - Diagnosis and Treatment

HCAP & CAP – those presenting to the
Diagnosis and Treatment ... hospital with pneumonia ... that developed pneumonia ... Community #Diagnosis #Management ... #Treatment #InfectiousDisease
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... Community-Acquired Pneumonia ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... #Regimen #Management
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Suggested Empiric Treatment ... Ventilator-Associated Pneumonia ... Are Appropriate #Management ... #InfectiousDiseases
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Community Acquired Pneumonia ... community-acquired pneumonia ... Corticosteroids #Adjuvant #InfectiousDiseases ... #Pharmacology #Management ... #Treatment #Indications
IDSA Risk Factors for Multidrug-Resistant Pathogens 

#Diagnosis #Management #InfectiousDiseases #MDRO #RiskFactors #HAP #VAP #HCAP #IDSA2016 #Guidelines
IDSA Risk Factors ... #Diagnosis #Management ... #InfectiousDiseases ... IDSA2016 #Guidelines #Pneumonia
IDSA Recommended therapy for patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens #Duration #IDSA
IDSA Recommended ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... Regimens #Duration #IDSA
Treatment of Latent Tuberculosis Infection
 - 3 mos isoniazid plus rifapentine given once weekly (Preferred)
 -
Treatment of Latent ... #Tuberculosis #treatment ... #management #infectiousdiseases ... #regimens #comparison